Literature DB >> 11138633

Proton MR spectroscopy of the brain.

S R Maheshwari1, G M Fatterpekar, M Castillo, S K Mukherji.   

Abstract

Magnetic resonance spectroscopy (MRS) has been shown to be an effective noninvasive diagnostic tool that can be used to monitor serially biochemical and metabolic changes in serial disease processes that affect the brain. MRS is now a clinical tool that is reimbursable. This article reviews MRS physics, techniques, pulse sequences, and the clinical applications of MRS.

Entities:  

Mesh：

Year:  2000        PMID： 11138633     DOI： 10.1016/s0887-2171(00)90036-2

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN： 0887-2171            Impact factor:   1.875


  9 in total

1.  Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

Review 2.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

3.  MR spectroscopy detects lipid peaks in cerebrotendinous xanthomatosis.

Authors:  E K Embiruçu; M C G Otaduy; A K Taneja; C C Leite; Fernando Kok; L T Lucato
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

4.  The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant.

Authors:  E C Lima; M C G Otaduy; M Tsunemi; R Pincerato; E F Cardoso; S Rosemberg; P H Aguiar; G G Cerri; C C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

5.  A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy.

Authors:  Dong Guo; Jiafeng Liu; Yanping Li; Qingqing Chen; Yunzheng Zhao; Xinwei Guo; Shuchai Zhu; Shengjun Ji
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

6.  Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity.

Authors:  M Petrou; R E Harris; B R Foerster; S A McLean; A Sen; D J Clauw; P C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

7.  Thalamic metabolic alterations with cognitive dysfunction in idiopathic trigeminal neuralgia: a multivoxel spectroscopy study.

Authors:  Yuan Wang; Dan Li; Faxiu Bao; Shaohui Ma; Chenguang Guo; Chenwang Jin; Ming Zhang
Journal:  Neuroradiology       Date:  2014-05-13       Impact factor: 2.804

8.  Evaluation of Metabolite Changes in the Occipital Cortex of Patients with Idiopathic Infantile Nystagmus or Bilateral Ametropic Amblyopia by Magnetic Resonance Spectroscopy.

Authors:  Ismail Konus; Ercan Ozsoy; Peykan Turkcuoglu; Sinan Emre; Fulya Duman
Journal:  Korean J Ophthalmol       Date:  2019-10

9.  Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy.

Authors:  Congli Jia; Zhengquan Li; Dong Guo; Zhen Zhang; Jingming Yu; Guangdong Jiang; Xiaobo Xing; Shengjun Ji; Feng Jin
Journal:  Onco Targets Ther       Date:  2020-12-22       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.